Point of care Diagnostics Market (2023-2030)
Point of care Diagnostics Market is expected to reach $43.1 billion by 2030, at a CAGR of 5.1% from 2023–2030.
- Published
- May 2023
- Pages
- 395
- Format
- PDF + Excel
- Report ID
- MR-99
- Base year
- 2022
- 2030 · FORECAST
- $43.10B
- 2030
- $43.10B
- CAGR 2023–2030
- 5.1%
2022 baseline · 2023–2030 forecast at 5.1% CAGR · hover a bar for the value
Key highlights
Point of care Diagnostics Market is expected to reach $43.1 billion by 2030, at a CAGR of 5.1% from 2023–2030.
The Molecular Diagnostics Platform Segment is Expected to Register the Highest CAGR During the Forecast Period
The blood glucose monitoring segment is expected to account for the largest share of the global POC diagnostics market.
The blood sample type segment is expected to grow at the highest CAGR during the forecast period.
The Home Care/Self-Testing Segment is Expected to Register the Highest CAGR during the Forecast Period
Asia-Pacific is expected to register the highest CAGR during the forecast period. Asia-Pacific is becoming an attractive market for healthcare product manufacturers due to the continuous improvement in the healthcare infrastructure, the rising number of hospitals, and growing government investment in this sector.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2023–2030 |
| Market Size (2030) | USD 43.10 billion |
| CAGR (2023–2030) | 5.1% |
| Format | PDF, Excel & Cloud Portal · 395 pages |
| Segments Covered | By Application: Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis · By Platform: LFA, Molecular · By Sample · By End User |
Report overview
Segments covered: application, platform, sample, end user.
The growth of this market is driven by the increasing prevalence of chronic diseases, innovations in PoC testing, development of CLIA-waived PoC testing, and lack of Skilled technicians for performing lab tests. In addition, emerging markets and healthcare professionals’ increasing preference for PoC tests over lab tests are expected to offer significant market growth opportunities. However, pricing pressure due to fluctuations in reimbursements restrains the growth of this market.
PoC diagnostic kits are pre-packaged sets of materials and reagents used for performing tests.
These diagnostic kits are user-friendly, with clear instructions for use and require minimal training, making them ideal for use in settings with limited access to trained laboratory personnel, such as rural or remote areas.
Other End Users (Other end users include nursing homes, long-term care centers, pharmacies, urgent care facilities, schools, airports, hotels, and workplaces)
Report infographic
Point of care Diagnostics Companies
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years. The key players operating in the global point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and bioMérieux S.A. (France).
Scope of Point of care Diagnostics Market Report:
Point-of-care Diagnostics Market Assessment, by Platform
- Lateral Flow Assays
- Molecular Diagnostics
- Other Platforms
(Note: Other platforms majorly include coagulation tests, dipsticks, cholesterol and glucose monitoring systems, and other point-of-care diagnostic platforms)
Point-of-care Diagnostics Market Assessment, by Sample Type
- Blood Sample
- Nasopharyngeal Swab
- Urine Sample
- Saliva Sample
- Other Sample Types
(Other sample types include stool, cervical swab, buccal swab, hair, vaginal swab, and semen)
Market dynamics
2 factors across 2 forcesEmerging Markets Create an Opportunity for the Market Growth
Emerging economies are fueling the demand for healthcare services and treatments due to rapid urbanization, improving healthcare infrastructures, increasing healthcare expenditures, growing healthcare insurance coverage, rising disposable incomes, and the growing prevalence of non-communicable and infectious diseases.
According to World Bank data, the total population in emerging countries is projected to reach 3.4 billion by 2050. Similarly, diabetes cases in emerging countries are rising. According to the IDF Diabetes Atlas 2021, diabetes cases in South Africa, India, Malaysia, Brazil, China, and Thailand increased from 171.6 million in 2011 to 245.5 million in 2021, indicating the high potential for the adoption of point-of-care diagnostic kits for blood glucose screening.
Moreover, growing urbanization and rising GDP per capita drive the demand for healthcare services and treatments in emerging economies such as South Africa, India, Brazil, China, Bangladesh, and Thailand. Growing urbanization indicates higher wages, a better quality of life, and improved access to healthcare services. Therefore, growing urbanization in emerging economies is expected to drive the development of healthcare systems, increasing people’s access to healthcare services and leading to the proliferation of hospitals, clinics, and diagnostic laboratories in these countries.
Table of contents
13 chapters · 146 sections · 395 pages · click to expandSegmental analysis
| Segment | Largest share (2023) | Fastest growth (2023–2030) |
|---|---|---|
| By Offering | Consumables | — |
| By Platform | — | Molecular diagnostics |
| By Application | Blood Glucose Monitoring | — |
| By Sample Type | — | Blood sample type |
| By End User | — | — |
By Offering
- The global point-of-care diagnostics market is segmented into consumables, instruments, and software and services.
- The consumables segment is expected to account for the largest share of the global point-of-care diagnostics market.
- The large market share of this segment is attributed to the benefits offered by point-of-care diagnostics kits, such as ease of use, portability, and accuracy.
By Platform
- The Molecular Diagnostics Platform Segment is Expected to Register the Highest CAGR During the Forecast Period
- The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period.
- The growth of this segment is driven by the high sensitivity and accuracy of these tests, the growing need for advanced diagnostic techniques, and the widening applications of molecular detection tests in various fields.
By Application
- The blood glucose monitoring segment is expected to account for the largest share of the global POC diagnostics market.
- The increased prevalence of diabetes and the need for glucose monitoring devices increased the demand for blood glucose monitoring PoC diagnostics devices.
- Blood Glucose Monitoring
- Blood-borne Infection Testing Hepatitis
- Influenza
- Pneumonia
- Salmonellosis
- Pregnancy Testing
By Sample Type
- The blood sample type segment is expected to grow at the highest CAGR during the forecast period.
- The growth of this segment is driven by the availability of a wide range of tests that can be conducted using blood samples, the growing prevalence of chronic diseases, and an increasing awareness among consumers about the importance of self-monitoring.
By End User
- The Home Care/Self-Testing Segment is Expected to Register the Highest CAGR during the Forecast Period
- The fast growth of the home care/self-testing segment is primarily attributed to the increasing prevalence of chronic diseases requiring long-term care and frequent monitoring, increasing home healthcare spending, growing awareness about home care, and the increasing availability of user-friendly and advanced POC diagnostic products.
- For instance, in the U.S., home healthcare spending increased from USD 88,800 million in 2015 to USD 1,17,100 million in 2020.
Geographic analysis
Asia-Pacific
Fastest growthAsia-Pacific is expected to register the highest CAGR during the forecast period. Asia-Pacific is becoming an attractive market for healthcare product manufacturers due to the continuous improvement in the healthcare infrastructure, the rising number of hospitals, and growing government investment in this sector. Accelerated economic growth in many countries of the Asia-Pacific region has relatively increased the focus of various governments on the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure. Asia-Pacific: Fastest Growing Regional Market China Japan India Rest of Asia-Pacific
Europe
U.K. Germany France Italy Spain Rest of Europe
Frequently asked questions
The point-of-care diagnostics market study covers the market sizes & forecasts for various point-of-care diagnostics products used in the healthcare sector. The report involves the value analysis of various segments and subsegments of the point-of-care diagnostics market at the regional and country levels.
Cite this report
Meticulous Research. (2023). Point of care Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2023-2030) (Report No. MR-99). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871